L. Foucault-Fruchard

An automated alert system based on the p-Tau/Tau ratio to quickly inform health professionals upon a suspected case of sporadic Creutzfeldt-Jakob disease.

É. Beaufils, D. Dufour‐Rainfray, L. Foucault-Fruchard, 2020, Journal of the Neurological Sciences.

Alpha-7 nicotinic acetylcholine receptor agonist treatment in a rat model of Huntington's disease and involvement of heme oxygenase-1

C. Tronel, S. Chalon, S. Bodard, 2018, Neural regeneration research.

Neuroprotective effect of the alpha 7 nicotinic receptor agonist PHA 543613 in an in vivo excitotoxic adult rat model

G. Page, F. Dollé, Annelaure Damont, 2017, Neuroscience.

Neuroprotective and anti-inflammatory effects of a therapy combining agonists of nicotinic α7 and σ1 receptors in a rat model of Parkinson’s disease

C. Tronel, S. Chalon, S. Routier, 2020, Neural regeneration research.

Reassessment of inappropriate prescriptions of proton pump inhibitors in elderly in-patients: It's time to take action.

F. Maillot, A. Bigot, L. Foucault-Fruchard, 2020, Annales pharmaceutiques francaises.

Therapeutic potential of α7 nicotinic receptor agonists to regulate neuroinflammation in neurodegenerative diseases

L. Foucault-Fruchard, D. Antier, Laura Foucault-Fruchard, 2017, Neural regeneration research.

Compared benefits of educational programs dedicated to diabetic patients with or without community pharmacist involvement

L. Foucault-Fruchard, D. Antier, Peggy Renoult-Pierre, 2020, Primary Health Care Research & Development.

The contributions of metabolomics in the discovery of new therapeutic targets in Alzheimer's disease

É. Beaufils, D. Dufour‐Rainfray, P. Emond, 2021, Fundamental & clinical pharmacology.

Why is there no biosimilar of Erbitux®?

D. Guillarme, V. D’Atri, A. Beck, 2023, Journal of pharmaceutical and biomedical analysis.